Public Policy Committee and Advocacy
Closely monitors Congressional and regulatory activity on homeopathy-related issues to analyze their impact and take action as needed to ensure that homeopathy as a healthcare option is accessible to all.
Why is advocacy important to homeopathy?
Healthcare is a major industry in the United States. Healthcare costs continue to rise yet Americans are less and less healthy with a significant array of chronic and life-threatening diseases. More and more people are becoming dissatisfied with mainstream medicine and the reliance on drugs that often carry with them serious side effects requiring additional drugs. Many people are seeking alternative and complementary treatments, which include homeopathy and other integrative health modalities.
Homeopathy has become a major player in the healthcare market in recent years with hundreds of millions of dollars in sales annually. With this increase in popularity and sales, homeopathy has come under scrutiny from the Food and Drug Administration and the Federal Trade Commission, both Federal regulatory agencies. This scrutiny has been aimed at labeling and claims on over-the-counter homeopathic products as well as safety and effectiveness.
This increased scrutiny alerted the homeopathic community to a potentially larger battle in the future to protect access to homeopathic care as a viable healthcare alternative. We must be prepared to advocate for homeopathy in every way we can – for individual patients and their right to choose their healthcare treatment, for changes to the healthcare system to ensure it is inclusive of integrative health alternatives, and for legislative changes to protect out rights to make healthcare decisions consistent with our beliefs and values.
We become more effective advocates when we thoroughly understand the issues we face.